2024 Year in Review

2024 was certainly a year of transformation. We recognized 50 years of grassroots fundraising and advocacy in Canada and in November we became Breakthrough T1D™ Canada. And while we now have a new name and look, our mission remains the same. We are as steadfast as ever about reaching our ultimate goal, a world free from type 1 diabetes (T1D).

Watch: We are Breakthrough T1D

And it is always because of our incredible community of donors, volunteers, and supporters that we never wavered in our mission, seeing progress and breakthroughs across all fields of T1D research. And with successful events and advocacy initiatives across the country, we continued to strengthen our relationship with the amazing T1D community.   

From the generosity of our donors, Breakthrough T1D Canada witnessed another transformative year– committing substantive funding to research, developing our partnerships in academia with new fellowships and grants, continuing to support both newly diagnosed families, and our adult T1D community, reinforcing our commitment to being there for anyone living with T1D at any age and any stage of their journey.

And while we work relentlessly towards cures, we continue to try to improve the lives today of the estimated 300,000 Canadians with T1D, through research, advocacy and community engagement.

Highlights from the past year included: 

T1D research highlights 

In cell replacement: 

In disease-modifying therapies: 

In treatments to improve lives: 

  • The Breakthrough T1D-CIHR Partnership to Defeat Diabetes announce 5 new grants in Knowledge Mobilization,  to provide researchers and knowledge users the opportunity to work together to use research evidence to improve health services, programs, and policies.
  • Funding programs devoted to improving mental health care and outcomes for people with T1D.
  • Renewed our funding of the BETTER project, a Canadian research initiative aimed at improving the lives of people with T1D.

In screening: 

  • Breakthrough T1D Canada and Sanofi Canada partner to raise awareness about autoimmune type 1 diabetes and the critical role of screening in its early detection.
  • Continued work by CanScreen T1D, a new Canadian T1D screening research consortium led by Dr. Diane Wherrett.  
  • Breakthrough T1D continues to help facilitate screening for relatives of those with T1D across Canada via TrialNet.

In clinical trials: 

To read more about research updates and stories of people living with T1D, please visit www.breakthrought1d.ca/blog

As we head into 2025, we pause and reflect on how truly grateful we are for the support of our donors, volunteers and the commitment of the T1D community. Thank you! Together, as we drive toward curing type 1 diabetes, we help to make every day better for the people living with it. 

Sign up for our newsletter and stay connected